Diffusion-weighted (DW) MRI in lung cancers: ADC test-retest repeatability

[1] O'Flynn EA(2011)Functional magnetic resonance: biomarkers of response in breast cancer Breast Cancer Res 13 204-192

[2] DeSouza NM(2011)Metastatic ovarian and primary peritoneal cancer: assessing chemotherapy response with diffusion-weighted MR imaging--value of histogram analysis of apparent diffusion coefficients Radiology 261 182-2920

[3] Kyriazi S(2014)Assessment of treatment response by total tumor volume and global apparent diffusion coefficient using diffusion-weighted MRI in patients with metastatic bone disease: a feasibility study PLoS One 9 2915-566

[4] Collins DJ(2016)Magnetic resonance imaging of pulmonary nodules: accuracy in a granulomatous disease–endemic region Eur Radiol 26 556-26

[5] Messiou C(2016)Apparent diffusion coefficient values of diffusion-weighted imaging for distinguishing focal pulmonary lesions and characterizing the subtype of lung cancer: a meta-analysis Eur Radiol 26 9-825

[6] Pennert K(2015)The emerging science of quantitative imaging biomarkers terminology and definitions for scientific studies and regulatory submissions Stat Methods Med Res 24 813-67

[7] Davidson RL(2015)Metrology standards for quantitative imaging biomarkers Radiology 277 27-511

[8] Giles SL(2015)Quantitative imaging biomarkers: a review of statistical methods for technical performance assessment Stat Methods Med Res 24 502-896

[9] Blackledge MD(2014)Diffusion-weighted magnetic resonance imaging for assessment of lung lesions: repeatability of the apparent diffusion coefficient measurement Eur Radiol 24 892-88

[10] Collins DJ(2016)Inter-and intraobserver agreement of ADC measurements of lung cancer in free breathing, breath-hold and respiratory triggered diffusion-weighted MRI Clin Imaging 40 135841-604

[1] O'Flynn EA(2011)Functional magnetic resonance: biomarkers of response in breast cancer Breast Cancer Res 13 204-192

[2] DeSouza NM(2011)Metastatic ovarian and primary peritoneal cancer: assessing chemotherapy response with diffusion-weighted MR imaging--value of histogram analysis of apparent diffusion coefficients Radiology 261 182-2920

[3] Kyriazi S(2014)Assessment of treatment response by total tumor volume and global apparent diffusion coefficient using diffusion-weighted MRI in patients with metastatic bone disease: a feasibility study PLoS One 9 2915-566

[4] Collins DJ(2016)Magnetic resonance imaging of pulmonary nodules: accuracy in a granulomatous disease–endemic region Eur Radiol 26 556-26

[5] Messiou C(2016)Apparent diffusion coefficient values of diffusion-weighted imaging for distinguishing focal pulmonary lesions and characterizing the subtype of lung cancer: a meta-analysis Eur Radiol 26 9-825

[6] Pennert K(2015)The emerging science of quantitative imaging biomarkers terminology and definitions for scientific studies and regulatory submissions Stat Methods Med Res 24 813-67

[7] Davidson RL(2015)Metrology standards for quantitative imaging biomarkers Radiology 277 27-511

[8] Giles SL(2015)Quantitative imaging biomarkers: a review of statistical methods for technical performance assessment Stat Methods Med Res 24 502-896

[9] Blackledge MD(2014)Diffusion-weighted magnetic resonance imaging for assessment of lung lesions: repeatability of the apparent diffusion coefficient measurement Eur Radiol 24 892-88

[10] Collins DJ(2016)Inter-and intraobserver agreement of ADC measurements of lung cancer in free breathing, breath-hold and respiratory triggered diffusion-weighted MRI Clin Imaging 40 135841-604